Reliq Health Technologies Stock Price To Sales
| RHT Stock | CAD 0.22 0.00 0.00% |
Reliq Health Technologies fundamentals help investors to digest information that contributes to Reliq Health's financial success or failures. It also enables traders to predict the movement of Reliq Stock. The fundamental analysis module provides a way to measure Reliq Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reliq Health stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 210.08 | 279.47 |
Reliq | Price To Sales |
Reliq Health Technologies Company Price To Sales Analysis
Reliq Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Reliq Health Price To Sales | 3.19 X |
Most of Reliq Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reliq Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Reliq Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Reliq Health is extremely important. It helps to project a fair market value of Reliq Stock properly, considering its historical fundamentals such as Price To Sales. Since Reliq Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Reliq Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Reliq Health's interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Reliq Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Reliq Health Technologies has a Price To Sales of 3.1909 times. This is 33.1% lower than that of the Health Care Technology sector and 88.14% lower than that of the Health Care industry. The price to sales for all Canada stocks is 72.06% higher than that of the company.
Reliq Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reliq Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reliq Health could also be used in its relative valuation, which is a method of valuing Reliq Health by comparing valuation metrics of similar companies.Reliq Health is currently under evaluation in price to sales category among its peers.
Reliq Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Reliq Health from analyzing Reliq Health's financial statements. These drivers represent accounts that assess Reliq Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Reliq Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 30.8M | 36.5M | 76.6M | 87.0M | 2.4M | 2.3M | |
| Enterprise Value | 30.4M | 37.0M | 76.8M | 87.1M | 2.4M | 2.3M |
Reliq Fundamentals
| Return On Equity | -0.0449 | ||||
| Return On Asset | -0.053 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 43.39 M | ||||
| Shares Outstanding | 196.76 M | ||||
| Shares Owned By Insiders | 1.76 % | ||||
| Shares Owned By Institutions | 2.81 % | ||||
| Number Of Shares Shorted | 504.11 K | ||||
| Price To Book | 5.12 X | ||||
| Price To Sales | 3.19 X | ||||
| Revenue | 14.62 M | ||||
| Gross Profit | 5.3 M | ||||
| EBITDA | (1.21 M) | ||||
| Net Income | (8.17 M) | ||||
| Cash And Equivalents | 1.92 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 305 K | ||||
| Current Ratio | 5.40 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (8.03 M) | ||||
| Short Ratio | 13.30 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.75 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 46.65 M | ||||
| Total Asset | 10.27 M | ||||
| Retained Earnings | (69.87 M) | ||||
| Working Capital | 3.26 M | ||||
| Net Asset | 10.27 M |
About Reliq Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.